$21,767,964.99 stock sale planned under Rule 144 for JNJ (NYSE: JNJ)

Rhea-AI Filing Summary

An affiliate of the issuer filed a notice to sell 89,654 shares of common stock under Rule 144. The shares are planned to be sold on the NYSE through Fidelity Brokerage Services LLC with an aggregate market value of $21,767,964.99 as stated in the filing.

The securities were recently acquired through restricted stock vesting and stock option exercises between 02/13/2026 and 02/17/2026, with consideration described as compensation or cash. Shares outstanding were 2,409,898,936 as of the data provided, which serves as a baseline figure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	89654	21767964.99	2409898936	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Restricted Stock Vesting	Issuer			22787	02/13/2026	Compensation
Common	02/15/2026	Restricted Stock Vesting	Issuer			2174	02/15/2026	Compensation
Common	02/17/2026	Options Granted - 02/13/2017	Issuer			19241	02/17/2026	Cash
Common	02/17/2026	Options Granted - 02/12/2018	Issuer			12066	02/17/2026	Cash
Common	02/17/2026	Options Granted - 02/11/2019	Issuer			33386	02/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for JNJ disclose?

The Form 144 discloses an affiliate’s intent to sell 89,654 common shares on the NYSE through Fidelity Brokerage Services LLC, with an aggregate stated market value of $21,767,964.99. It is a notice of a planned resale of restricted or controlled securities.

How many JNJ shares are planned to be sold and at what value?

The notice covers 89,654 common shares with an aggregate market value of $21,767,964.99. These figures come directly from the securities information section, which lists both the number of shares to be sold and the corresponding market value at the time of the filing.

How were the JNJ shares in this Form 144 acquired?

The shares were acquired through restricted stock vesting and the exercise of stock options between 02/13/2026 and 02/17/2026. Consideration is described as compensation for vested restricted stock and cash payments for shares issued from option grants on earlier grant dates.

When is the planned sale date for the JNJ shares in this Form 144?

The approximate sale date listed is 02/17/2026. This date appears in the securities information table as the approximate date of sale for the 89,654 common shares that are intended to be sold on the NYSE through the named broker.

How many JNJ shares are outstanding according to this Form 144?

The filing states that 2,409,898,936 common shares are outstanding. This figure appears in the securities information table as the number of shares or other units outstanding and serves as a context baseline relative to the amount being proposed for sale.

What representation does the seller make in this JNJ Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. The form also warns that intentional misstatements or omissions can constitute federal criminal violations under 18 U.S.C. 1001.